| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |